# Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori

> **NCT02776371** · PHASE4 · COMPLETED · sponsor: **Shandong University** · enrollment: 301 (actual)

## Conditions studied

- Helicobacter Pylori Eradication Rate

## Interventions

- **DRUG:** Modified non-clarithromycin triple therapy
- **DRUG:** Sequential therapy

## Key facts

- **NCT ID:** NCT02776371
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-01
- **Final completion:** 2018-02
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776371, "Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02776371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*